Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV
Completed · Phase 3
Conditions studied: HIV Infections
In brief
Pregnant women infected with HIV who take anti-HIV medications during pregnancy lower the risk of passing HIV to their infants. This study will compare how well two different combinations of anti-HIV medications control HIV in pregnancy, and whether these combinations of drugs are effective in preventing HIV from being transmitted from a pregnant woman to her baby. The two combinations are abacavir/lamivudine/zidovudine (ABC/3TC/ZDV) and zidovudine/lamivudine (ZDV/3TC) plus lopinavir/ritonavir (LPV/RTV).
Key facts
- Study ID
- NCT00086359
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 19
- Starts
- 2004-07-01
- Expected to finish
- 2007-09-01
- Last updated by the study team
- 2021-11-01
Who can join
Age: 13 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Usc La Nichd Crs — Los Angeles, California, United States
- UCSD Mother-Child-Adolescent Program CRS — San Diego, California, United States
- Univ. of Miami Ped. Perinatal HIV/AIDS CRS — Miami, Florida, United States
- Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program — Chicago, Illinois, United States
- Bronx-Lebanon CRS — The Bronx, New York, United States
- Regional Med. Ctr. at Memphis — Memphis, Tennessee, United States
- Texas Children's Hosp. CRS — Houston, Texas, United States
- San Juan City Hosp. PR NICHD CRS — San Juan, Puerto Rico
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.